Commentary

Recently published articles about Commentary

JCP
ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference
Commentary

ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.
JCP
Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters
Commentary

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters

July 1, 2026

This commentary argues that psychiatric participation in MAID differs meaningfully from traditional capacity evaluations and conventional suicide prevention and therefore demands its own practice standards.
JCP
The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context
Commentary

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context

June 22, 2026

The authors discuss the findings of a recent study by Rahamim et al.
,
JCP
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
Commentary

Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets

June 1, 2026

Evidence-based prescription of GLP-1 RAs in persons with serious mental illness and/or substance use disorders holds promise to improve their health and wellbeing and possibly reduce excess mortality.
JCP
The Patient Perspective on Tardive Dyskinesia
Commentary

The Patient Perspective on Tardive Dyskinesia

April 29, 2026

Patients’ perspectives on their experiences with tardive dyskinesia provide critical insights that go beyond the information provided by clinical assessments.
JCP
The Demoralization Construct in Clinical Practice and Research
Commentary

The Demoralization Construct in Clinical Practice and Research

March 25, 2026

It is important to acknowledge demoralization as a separate diagnosis, rather than merely a specifier, because demoralization may occur by itself, in the absence of any other disorder or...

Recent JCP Articles on Commentary

JCP
Gender-Affirming Perinatal Psychiatry for Transgender and Gender Diverse People
Commentary

Gender-Affirming Perinatal Psychiatry for Transgender and Gender Diverse People

November 10, 2025

Considerations for providing perinatal psychiatric care to transgender and gender diverse patients are addressed
, ,
JCP
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
Commentary

Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug

October 6, 2025

The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...
, , , et al
JCP
Why Getting Major Depression Right Matters—For Mothers, Babies, and All of Us
Commentary

Why Getting Major Depression Right Matters—For Mothers, Babies, and All of Us

September 24, 2025

Commenting on an FDA panel discussion on SSRI use during pregnancy, Dr Payne emphasizes the importance of precision when discussing treatments for mental health conditions.

Recent PCC Articles on Commentary

PCC
An Update on the Future of Wilson Disease Management
Commentary

An Update on the Future of Wilson Disease Management

November 29, 2022

Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen...
PCC
Gandhian Concepts on Mental Health in Contemporary COVID-19 Pandemic Times
Commentary

Gandhian Concepts on Mental Health in Contemporary COVID-19 Pandemic Times

April 19, 2022

In this commentary, the authors discuss Gandhi’s views on mental health, especially in the context of the COVID-19 pandemic.
, , , et al
PCC
US Suicide Rates and Impact of Major Disasters
Commentary

US Suicide Rates and Impact of Major Disasters

April 12, 2022

This commentary explores the impact of major disasters on suicide rates, especially in the context of the COVID-19 pandemic.
, , , et al

Featured Commentary Research

PCC
Willful Dissociation and Hypnosis: Strategies for Primary Care
Rounds in the General Hospital

Willful Dissociation and Hypnosis: Strategies for Primary Care

September 3, 2026

A myriad of affective, behavioral, cognitive symptoms, and problems, such as pain, can be altered by use of willful dissociation in the context of receiving medical care
, , , et al
PCC
Recognition and Management of Catatonia
Narrative Review

Recognition and Management of Catatonia

September 3, 2026

Catatonia is a highly treatable yet frequently missed syndrome. Improved recognition, systematic screening, and timely treatment remain essential to reducing morbidity and improving patient outcomes
,
JCP
Evaluation of Sexual Function With Adjunctive Lumateperone in Major Depressive Disorder
Original Research

Evaluation of Sexual Function With Adjunctive Lumateperone in Major Depressive Disorder

September 2, 2026

Adjunctive lumateperone 42 mg did not worsen sexual functioning and was not associated with treatment-related sexual dysfunction.
, , , et al
JCP
Biography Inscribed in Biology: Diagnostic Criteria for Psychosomatic Research and the Embodiment of Lived Experience
Commentary

Biography Inscribed in Biology: Diagnostic Criteria for Psychosomatic Research and the Embodiment of Lived Experience

March 25, 2026

The DCPR framework, with its emphasis on allostatic overload, provides evidence that biography becomes biology and that lived experience is inscribed into our physiological systems.
JCP
Mind-Body Integration and East-West Fusion for Modern Medicine: Insights from the Diagnostic Criteria for Psychosomatic Research
Commentary

Mind-Body Integration and East-West Fusion for Modern Medicine: Insights from the Diagnostic Criteria for Psychosomatic Research

March 25, 2026

Clinimetrics not only lays the methodological foundation for the promotion of the DCPR but also shows potential in interdisciplinary applications.
,
JCP
Benzodiazepines as Special Risk Medications
Commentary

Benzodiazepines as Special Risk Medications

February 18, 2026

In light of a study examining current benzodiazepine prescribing trends, Dr Silberman comments on appropriate clinical use of these medications.
JCP
Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step
Commentary

Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step

December 22, 2025

The authors recommend moving toward a precision medicine approach to suicide prevention that considers the person, their circumstances and biology, treatment delivery context, and conditions that contribute to the...
, , , et al
JCP
The Goldilocks Problem: Balancing Internal Validity with Generalizability in Clinical Trials
Commentary

The Goldilocks Problem: Balancing Internal Validity with Generalizability in Clinical Trials

November 26, 2025

The author discusses a recent analysis by Zimmerman and Snyder focusing on the generalizability of PTSD treatment trials.
JCP
MAOI Antidepressants: A History Being Rewritten
Commentary

MAOI Antidepressants: A History Being Rewritten

November 26, 2025

Members of the International MAOI Expert Group discuss historical use of MAOIs, consider their efficacy and safety, and underscore the importance of reassessing their place in treatment algorithms.
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe